Differential memory enrichment of cytotoxic CD4 T cells in Parkinson’s disease patients reactive to α-synuclein
Parkinson's disease (PD) is a complex neurodegenerative disease with a largely unknown etiology. Although the loss of dopaminergic neurons in the substantia nigra pars compacta is the pathological hallmark of PD, neuroinflammation also plays a fundamental role in PD pathology. We have previously reported that PD patients have increased frequencies of T cells reactive to peptides from α-synuclein (α-syn). However, not all PD participants respond to α-syn. Furthermore, we have previously found that CD4 T cells from PD participants responding to α-syn (PD_R) are transcriptionally distinct from PD participants not responding to α-syn (PD_NR). To gain further insight into the pathology of PD_R participants, we investigated surface protein expression of 11 proteins whose genes had previously been found to be differentially expressed when comparing PD_R and healthy control participants not responding to α-syn (HC_NR). We found that Cadherin EGF LAG seven-pass G-type receptor 2 (CELSR2) was expressed on a significantly higher proportion of CD4 effector memory T cells (T<sub>EM</sub>) in PD_R compared to HC_NR. Single-cell RNA sequencing analysis of cells expressing or not expressing CELSR2 revealed that PD_R participants have elevated frequencies of activated T<sub>EM</sub> subsets and an almost complete loss of cytotoxic T<sub>EM</sub> cells. Flow cytometry analyses confirmed that Granulysin<sup>+</sup> CD4 cytotoxic T<sub>EM</sub> cells are reduced in PD_R. Taken together, these results provide further insight into the perturbation of T cell subsets in PD_R, and highlights the need for further investigation into the role of Granulysin<sup>+</sup> CD4 cytotoxic T<sub>EM</sub> in PD pathology.
Authors
- Irene Litvan (ORCID: https://orcid.org/0000-0002-3485-3445)
- Alessandro Sette (ORCID: https://orcid.org/0000-0001-7013-2250)
- Emil Johansson (ORCID: https://orcid.org/0000-0002-4712-3687)
- David Sulzer (ORCID: https://orcid.org/0000-0001-7632-0439)
- Antoine Freuchet (ORCID: https://orcid.org/0000-0002-9167-5454)
- Roy N. Alcalay (ORCID: https://orcid.org/0000-0002-5717-4875)
- April Frazier (ORCID: https://orcid.org/0000-0002-4722-7304)
- Jennifer G. Goldman (ORCID: https://orcid.org/0000-0001-5014-7535)
- Cecilia S. Lindestam Arlehamn (ORCID: https://orcid.org/0000-0001-7302-8002)
Institutions
- Statens Serum Institut (DK)
- Northwestern University (US)
- La Jolla Institute for Immunology (US)
- Shirley Ryan AbilityLab (US)
- Lund University (SE)
- Columbia University Irving Medical Center (US)
- Tel Aviv Sourasky Medical Center (IL)
- New York Psychoanalytic Society and Institute (US)
- University of California San Diego (US)
- Research Network (United States) (US)
- New York State Psychiatric Institute
- Columbia University (US)
Publication Details
- Journal
- npj Parkinson s Disease
- Published
- 2025-05-14
- DOI
- https://doi.org/10.1038/s41531-025-00981-6
- Citations
- 3
- Primary Topic
- Neuroinflammation and Neurodegeneration Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 2.53
Funders
- Michael J. Fox Foundation for Parkinson's Research
- Vetenskapsrådet